Capillary electrophoresis and matrix-assisted laser desorption/ionization-time of flight-mass spectrometry for analysis of the novel erythropoiesis-stimulating protein (NESP)

被引:30
作者
Sanz-Nebot, V [1 ]
Benavente, F [1 ]
Giménez, E [1 ]
Barbosa, J [1 ]
机构
[1] Univ Barcelona, Dept Analyt Chem, E-08028 Barcelona, Spain
关键词
capillary electrophoresis; erythropoietin; glycoforms; matrix-assisted laser desorption/ionization-time of flight-mass spectrometry; novel erythropoiesis-stimulating protein;
D O I
10.1002/elps.200410092
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
NESP (novel erythropoiesis-stimulating protein) is a recently approved hypergly-cosylated analogue of human erythropoietin (EPO) with a long-lasting effect. In this work, the capillary electrophoresis (CE) methodology proposed by the European Pharmacopoeia for the separation of EPO glycoforms has been modified for the separation of NESP glycoforms. Optimization of pH of the separation electrolyte has been fundamental in order to achieve baseline resolution of seven peaks corresponding to NESP glycoforms. Intact NESP has also been characterized by matrix-assisted laser desorption/ionization-time of flight-mass spectrometry (MALDI-TOF-MS). An accurate approximation to an average molecular mass of the NESP molecule has been obtained, taking into account the strong influence of laser intensity upon the MALDI-TOF mass spectra found.
引用
收藏
页码:1451 / 1456
页数:6
相关论文
共 27 条
[1]   Epoetin alpha, epoetin beta and darbepoetin alfa: Two-dimensional gel electrophoresis isoforms characterization and mass spectrometry analysis [J].
Caldini, A ;
Moneti, G ;
Fanelli, A ;
Bruschettini, A ;
Mercurio, S ;
Pieraccini, G ;
Cini, E ;
Ognibene, A ;
Luceri, F ;
Messeri, G .
PROTEOMICS, 2003, 3 (06) :937-941
[2]  
Catlin DH, 2002, CLIN CHEM, V48, P2057
[3]   Amgen preserves erythropoietin monopoly for now [J].
Chahine, K .
NATURE BIOTECHNOLOGY, 2001, 19 (03) :188-188
[4]   Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin [J].
Egrie, JC ;
Dwyer, E ;
Browne, JK ;
Hitz, A ;
Lykos, MA .
EXPERIMENTAL HEMATOLOGY, 2003, 31 (04) :290-299
[5]   Development and characterization of novel erythropoiesis stimulating protein (NESP) [J].
Egrie, JC ;
Browne, JK .
BRITISH JOURNAL OF CANCER, 2001, 84 (Suppl 1) :3-10
[6]  
Fisher JW, 2003, EXP BIOL MED, V228, P1
[7]   The enigma of the metabolic fate of circulating erythropoietin (Epo) in view of the pharmacokinetics of the recombinant drugs rhEpo and NESP [J].
Jelkmann, W .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2002, 69 (5-6) :265-274
[8]   MATRIX DEPENDENCE OF METASTABLE FRAGMENTATION OF GLYCOPROTEINS IN MALDI TOF MASS-SPECTROMETRY [J].
KARAS, M ;
BAHR, U ;
STRUPAT, K ;
HILLENKAMP, F ;
TSARBOPOULOS, A ;
PRAMANIK, BN .
ANALYTICAL CHEMISTRY, 1995, 67 (03) :675-679
[9]   Comparative studies on the analysis of glycosylation heterogeneity of sialic acid-containing glycoproteins using capillary electrophoresis [J].
Kinoshita, M ;
Murakami, E ;
Oda, Y ;
Funakubo, T ;
Kawakami, D ;
Kakehi, K ;
Kawasaki, N ;
Morimoto, K ;
Hayakawa, T .
JOURNAL OF CHROMATOGRAPHY A, 2000, 866 (02) :261-271
[10]  
Landers JP, 1997, HDB CAPILLARY ELECTR